- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for hbc
Spring Cleaning for Financials: 2 to Sell, 2 to Buy
There’s a big difference between which companies to keep and which to dump. Here’s where these four names fall.
The Tesla Tumble: Why Now Is the Time to Dump TSLA Stock
Tesla continues to make fresh 52-week lows, with no sign of slowing. Here’s why TSLA stock remains a sell in this current market.
The 7 Best ETFs for a Set-and-Forget Portfolio
Worried about volatility rearing its ugly head? Then make sure your portfolio includes some of these best ETFs for all seasons.
10 Best Stocks for 2012: The Results Are In
Our contest to pick the best stock of 2012 went right down to the wire. Find out which of our experts’ picks fared best —…
Why the Financial Future Is Built Upon the Chinese Yuan
China is one of the world’s biggest economic powers and their currency, the Yuan, is slowly becoming the most important in the world
Buys and Sells in 38 Blue Chip Mega Cap Stocks
When you look at the broader stock market, the little guys often get lost in the shuffle. That’s because a small start-up or a penny…
Ranking InvestorPlace’s 10 Best Stocks for 2012 Through Q3
Another quarter has passed, further shaking up our 10 expert picks and leaving six in the black. Here’s how they rank heading into the final…
BC Stock Earnings: Brunswick Meets EPS, Beats Revenue for Q1 2024
BC stock results show that Brunswick met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Ranking InvestorPlace’s 10 Best Stocks for 2012 Through Q2
A rough Q2 has shaken our 10 expert picks, but more than half still are in the black through the first half of 2012. Here’s…
HBCP Stock Earnings: Home Bancorp Beats EPS, Beats Revenue for Q1 2024
HBCP stock results show that Home Bancorp beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Why Arrowhead Research (ARWR) Stock Is Soaring Today
Arrowhead Research stock was up on Thursday following positive results from a Phase 2 study of hepatitis B drug ARC-520.
HWC Stock Earnings: Hancock Whitney Beats EPS, Misses Revenue for Q1 2024
HWC stock results show that Hancock Whitney beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
9 – 10 of 240 results